InvestSMART

Ramsay Health Care Limited (ASX: RHC) - Announcements

- Current share price for RHC : $53.300

ASX company news and announcements for Ramsay Health Care Limited (RHC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Ramsay Health Care Limited (RHC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Ramsay Health Care Limited (RHC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Ramsay Health Care Limited (RHC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$12,303 Cash offer for Spire Healthcare - Change of Court Date 28 Jun 2021 6:22PM $63.580 $53.300 fallen by 16.17%
$12,303 Becoming a substantial holder 22 Jun 2021 8:24AM $64.810 $53.300 fallen by 17.76%
$12,303 Publication of Scheme Document 15 Jun 2021 4:19PM $64.260 $53.300 fallen by 17.06%
$12,303 Presentation & Speech - Recommended Cash Offer for Spire 26 May 2021 4:21PM $64.540 $53.300 fallen by 17.42%
$12,303 Recommended Cash Offer for Spire Healthcare Group 26 May 2021 4:20PM $64.540 $53.300 fallen by 17.42%
$12,303 Presentation to Macquarie Australia Conference 4 May 2021 8:21AM $67.090 $53.300 fallen by 20.55%
$12,303 Ramsay Ascribed Investment Grade Credit Rating From Fitch 4 May 2021 8:20AM $67.090 $53.300 fallen by 20.55%
$12,303 Dividend/Distribution - RHCPA 20 Apr 2021 5:17PM $66.780 $53.300 fallen by 20.19%
$12,303 French Government issues funding guarantee scheme details 19 Apr 2021 8:31AM $67.320 $53.300 fallen by 20.83%
$12,303 Update - Dividend/Distribution - RHCPA 25 Feb 2021 8:37AM $63.280 $53.300 fallen by 15.77%
$12,303 Dividend/Distribution - RHC 25 Feb 2021 8:33AM $63.280 $53.300 fallen by 15.77%
$12,303 Calendar of Key Dates 2021 25 Feb 2021 8:29AM $63.280 $53.300 fallen by 15.77%
$12,303 Half Year Financial Results Presentation 25 Feb 2021 8:25AM $63.280 $53.300 fallen by 15.77%
$12,303 Half Year Financial Results 25 Feb 2021 8:22AM $63.280 $53.300 fallen by 15.77%
$12,303 Half Yearly Report and Accounts 25 Feb 2021 8:21AM $63.280 $53.300 fallen by 15.77%
$12,303 Ceasing to be a substantial holder 24 Feb 2021 8:07AM $63.260 $53.300 fallen by 15.74%
$12,303 Becoming a substantial holder 23 Feb 2021 9:43AM $62.150 $53.300 fallen by 14.24%
$12,303 Ceasing to be a substantial holder 18 Feb 2021 11:30AM $63.160 $53.300 fallen by 15.61%
$12,303 RHC enters new agreement with NHS England 22 Dec 2020 8:18AM $62.500 $53.300 fallen by 14.72%
$12,303 RHC and MPL sign new HPPA 21 Dec 2020 8:34AM $62.640 $53.300 fallen by 14.91%
$12,303 Change of Director's Interest Notice 15 Dec 2020 4:14PM $63.400 $53.300 fallen by 15.93%
$12,303 Results of Meeting 24 Nov 2020 12:22PM $65.320 $53.300 fallen by 18.40%
$12,303 2020 AGM - Chairman & Managing Director Address & Presention 24 Nov 2020 9:52AM $65.310 $53.300 fallen by 18.39%
$12,303 Ramsay Health Care First Quarter Trading Update 13 Nov 2020 8:47AM $67.970 $53.300 fallen by 21.58%
$12,303 Becoming a substantial holder 30 Oct 2020 8:21AM $63.330 $53.300 fallen by 15.84%

326 - 350 of 761 results

Page 14 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.